---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-094676"
form_type: "8-K"
ticker: "COR"
cik: "0001140859"
company_name: "Cencora, Inc."
filed_at: "2026-08-12T16:38:08+00:00"
generated_at: "2026-08-12T16:39:06.743219+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Cencora discloses Walgreens volume shift; reaffirms FY2026 EPS guidance

## Summary
- Beginning July 1, 2026, certain Walgreens volume serviced outside the prime vendor agreement began moving away from Cencora.
- Prime vendor agreement unchanged and constitutes vast majority of Walgreens business.
- Volume shift fully contemplated in Aug 5, 2026 commentary on Q4 U.S. Healthcare Solutions expectations.
- Reaffirms FY2026 adjusted diluted EPS guidance of $17.75-$17.95.

## SEC filing metadata
- accession: 0001104659-26-094676
- form_type: 8-K
- ticker: COR
- cik: 0001140859
- company_name: Cencora, Inc.
- filed_at: 2026-08-12T16:38:08+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1140859/000110465926094676/0001104659-26-094676-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1140859/000110465926094676/tm2622984d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-094676
- JSON: https://secwatch.observer/filing/0001104659-26-094676.json
- Plain text: https://secwatch.observer/filing/0001104659-26-094676.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.